Rapid Micro Biosystems (RPID) Receivables (2020 - 2026)

Rapid Micro Biosystems has disclosed Receivables across 7 years of filings, most recently posting $6.5 million for Q1 2026.

• Receivables for Q1 2026 came in at $6.5 million, up 40.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.5 million (up 40.36% YoY), and the FY2025 annual result was $3.2 million, down 57.55% from the prior year.
• Receivables came in at $6.5 million for Q1 2026 at Rapid Micro Biosystems, up from $3.2 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $7.6 million in Q4 2024 to a low of $3.2 million in Q4 2025.
• The 5-year median for Receivables is $5.0 million (2024), against an average of $5.0 million.
• Across the five-year window, Receivables jumped 43.0% in 2023 and slumped 57.55% in 2025, its largest moves.
• Rapid Micro Biosystems' Receivables stood at $5.5 million in 2022, then gained by 2.08% to $5.6 million in 2023, then surged by 36.47% to $7.6 million in 2024, then plunged by 57.55% to $3.2 million in 2025, then soared by 100.56% to $6.5 million in 2026.
• The last three Receivables figures came in at $6.5 million (Q1 2026), $3.2 million (Q4 2025), and $5.5 million (Q3 2025), per Business Quant data.